Delivery Order SPE2DB24D2205-SPE2DB25FEEHF
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of 1,000 tablets of Synthroid 137 micrograms at a ceiling value of $2,134.25. This is a firm fixed-price delivery order with no set-aside designation, completed by July 31, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a competitive procurement...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,537.98 delivery order to AmerisourceBergen Drug Corp for 1,000 units of Synthroid 25 micrograms on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement under delivery order contract type. The award was placed to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the vendor is headquartered...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Synthroid 100 micrograms tablets in quantities of 1,000 units, with a ceiling value of $1,061.94. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is due for completion by September 16, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,838.73 to AmerisourceBergen Drug Corp for the supply of Synthroid 25 mcg in a quantity of 1,000 units. The contract was competitively awarded without set-aside restrictions under a firm fixed-price delivery order structure, with an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of 1,000 tablets of Synthroid 25 micrograms, with a ceiling value of $1,539.70. This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and is scheduled for completion by August 6, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,574.94 for 1,000 tablets of Synthroid 112 mcg on September 23, 2025, with completion expected by September 24, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,231.14 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 50 mcg. This firm fixed-price delivery order, issued on September 17, 2025, with completion targeted for September 18, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Synthroid 88 mcg tablets in quantities of 1,000 units. This competitively awarded, non-set-aside contract carries a ceiling value of $2,510.44 with firm fixed pricing and an ultimate completion date of September 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 75 mcg on June 17, 2025, with a ceiling value of $1,886.88. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract includes no set-aside designation, reflecting AmerisourceBergen's competitive standing in federal pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,213.91 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 175 mcg on September 10, 2025, with completion expected by September 11, 2025. This delivery order was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Synthroid is a synthetic thyroid hormone medication commonly...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEEHFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Synthroid 137 micrograms, valued at $55,921.07, with an ultimate completion date of July 1, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency and its Medical Supply Chain. The company's demonstrated capability to meet federal procurement requirements through open competition is evidenced by its consistent delivery of pharmaceuticals spanning multiple therapeutic domains, including specialty medications, generic and brand-name drugs, vaccines, and medical devices to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This Synthroid delivery order exemplifies the company's role as a critical vendor for federal military and veteran healthcare procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $55.9k | 6/30/25 |